The Missing Minorities The missing minorities or the inadequate representation of ethnic and racial minority groups in clinical trials taking place in the United States is currently of great concern. Although minority groups should not carry an unfair burden in clinical research, they also should not be excluded from participation ...

Global Clinical Trials: Language & Culture By Karen Politis Virk, MS Many emerging countries, such as India, China, Mexico, Brazil, and Russia, are rapidly becoming prominent outsourcing locations for clinical research. A wider availability of patients, low operational costs and positive patient attitudes towards global clinical trials has driven this ...

CLINICAL TRIALS IN SOUTH AFRICA                                                                                           ...

Clinical Trials in India: What are the Challenges? By Karen Politis Virk As demands for reducing drug development costs and achieving higher patient recruitment rates increase, India is projected to become a dominant clinical trial location. By 2011, it is expected that clinical trials in India will equal 15% of ...

CLINICAL TRIALS IN CENTRAL & EASTERN EUROPE: Multiple Cultures By Karen Politis Virk As costs for drug development in the United States (U.S.) increase, pharmaceutical and biotech companies are increasingly considering clinical studies abroad. This is in large part due to the fact that many countries can conduct clinical trials ...